Randomized phase III trial with a factorial design assessing the efficacy and safety of darolutamide and stereotactic dose-escalated radiotherapy in patients with high-risk localized prostate cancer: the PEACE 7 (GETUG-AFU 45) study protocol
The PEACE 7 protocol plans a 700-patient phase III trial testing darolutamide and a prostate stereotactic radiotherapy boost in men ...
